Canaccord Genuity Remains a Buy on Alnylam Pharma (ALNY)
In a report released yesterday, Whitney Ijem from Canaccord Genuity reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), with a ...
Fintel on MSN1d
Canaccord Genuity Initiates Coverage of LifeStance Health Group (LFST) with Buy Recommendation
Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...
Canaccord selling U.S. market-making division, focusing on core operations
Deal with Cantor Fitzgerald comes almost two years after Canaccord warned of a potentially ‘significant penalty’ related to ...
ASP Isotopes, Inc. (ASPI) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on ASP Isotopes, Inc. (ASPI – Research Report) yesterday and set a price ...
Canaccord Genuity Group Issues Pessimistic Forecast for LifeSpeak (TSE:LSPK) Stock Price
LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...
The Canadian Press on MSN3d
Canaccord Genuity selling U.S. wholesale market making business
Canaccord Genuity Group Inc. has signed a deal to sell its U.S. wholesale market making business to Cantor as part of a plan ...
Explore more
Canaccord Genuity places Wood Group 'under review'
Analysts at Canaccord Genuity placed their target price and rating on oilfield services business Wood Group under review on ...
Cantor to acquire Canaccord Genuity Group's U.S.-based Global Wholesale Market Making Business
Cantor, a premier investment bank, today announced it has entered into a definitive agreement to acquire Canaccord Genuity Group's U.S.-based wholesale market making business, which specializes in U.S ...
Canadian Mining Journal1d
TNM Podcast: Asset managers slow to gold trade, ft Canaccord Genuity’s Cam Currie on gold stocks
This week’s episode features Canaccord Genuity senior investment advisor Cam Currie in conversation with host Adrian ...
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies ...
Aeva, Arbe initiated with Buys due to 'future leaning' autonomous driving tech: CG
Aeva Technologies (NASDAQ:AEVA) and Arbe Robotics (NASDAQ:ARBE) both received Buy ratings due to their potential roles in the ...
Canaccord Genuity Sells Non-Core U.S. Wholesale Market-Making Business
Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...